Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Spring;42(2):266-273.
doi: 10.2337/cd23-0044. Epub 2023 Nov 10.

Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice

Autumn Stewart-Lynch  1   2 , Rebekah Meyers  2 , Dina Sidig  1 , Sea-Oh McConville  1 , Lindsay Heiple  1
Affiliations

Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice

Autumn Stewart-Lynch et al. Clin Diabetes. 2024 Spring.

Abstract

The American Diabetes Association advises clinicians of the potential for insulin overbasalization in the management of type 2 diabetes. Described as the titration of basal insulin beyond an appropriate dose, overbasalization increases risks for adverse effects such as hypoglycemia and weight gain without achieving the glycemic targets needed to optimally manage the disease. There is a need to determine the prevalence of and clinical factors that can lead to overbasalization. This study aimed to assess the prevalence of and characterize the patient variables associated with overbasalization in a family medicine practice.

PubMed Disclaimer

Conflict of interest statement

No potential conflicts of interest relevant to this article were reported.

Figures

Figure 1
Figure 1
Number and percentage of patients by daily insulin dose. Solid white = >1, white with black dots = 0.5, black and white stripes = 0.3 to <0.5, and solid black = <0.3 units/kg.
See this image and copyright information in PMC

References

    1. ElSayed NA, Aleppo G, Aroda VR, et al. ; American Diabetes Association . 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S140–S157 - PMC - PubMed
    1. Cowart K. Overbasalization: addressing hesitancy in treatment intensification beyond basal insulin. Clin Diabetes 2020;38:304–310 - PMC - PubMed
    1. Meece J. Basal insulin intensification in patients with type 2 diabetes: a review. Diabetes Ther 2018;9:877–890 - PMC - PubMed
    1. Umpierrez GE, Skolnik N, Dex T, Traylor L, Chao J, Shaefer C.. When basal insulin is not enough: a dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab 2019;21:1305–1310 - PMC - PubMed
    1. Anderson SL, Trujillo JM.. Type 2 diabetes mellitus. In Endocrine Secrets. 7th ed. McDermott MT, Ed. St. Louis, MO, Elsevier, 2020, p. 31–42